ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,268Medicare Part D Prescriptions Filled, Including Refills

Rank: 44 out of 337

$567K Total Retail Price of All Prescriptions

Rank: 55 out of 337

432 Patients Receiving at Least One Drug in Part D
74%Patients 65 Years and Older
49% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Rhode Island
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 432 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

17% of this provider’s 432 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 8,652 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$46 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Rhode Island
SIMVASTATIN 762 540 1 1
LISINOPRIL 644 509 2 2
ATENOLOL 508 380 3 10
OMEPRAZOLE 475 269 4 4
LEVOTHYROXINE SODIUM 356 264 5 5
ATORVASTATIN CALCIUM 354 283 6 7
METOPROLOL TARTRATE 354 297 6 6
HYDROCODONE-ACETAMINOPHEN 349 180 S3 8 13
FUROSEMIDE 342 293 9 8
METFORMIN HCL 326 254 10 12
HYDROCHLOROTHIAZIDE 303 246 11 9
AMLODIPINE BESYLATE 241 209 12 3
WARFARIN SODIUM 204 165 13 11
ZOLPIDEM TARTRATE 186 123 14 23
GABAPENTIN 185 110 15 20
GLIPIZIDE ER 146 100 16 69
PROAIR HFA 140 71 17 38
OXYCONTIN 131 14 S2 18 87
CITALOPRAM HBR 116 40 19 17
TRIAMTERENE-HCTZ 114 105 20 39
DOXAZOSIN MESYLATE 109 98 21 68
TRAMADOL HCL 100 31 22 32
CLOPIDOGREL 99 84 23 42
OXYCODONE-ACETAMINOPHEN 96 32 S2 24 84
TRAZODONE HCL 93 42 25 16
ALENDRONATE SODIUM 85 61 26 19
KLOR-CON M20 84 81 27 65
ROPINIROLE HCL 84 57 27 141
SERTRALINE HCL 83 56 29 18
METOPROLOL SUCCINATE 78 61 30 21
LOSARTAN POTASSIUM 77 73 31 15
FLUTICASONE PROPIONATE 75 38 32 34
PLAVIX 71 64 33 74
ENALAPRIL MALEATE 70 35 34 37
ADVAIR DISKUS 69 60 35 44
IBUPROFEN 67 22 36 64
OXYBUTYNIN CHLORIDE 67 52 36 143
SPIRONOLACTONE 66 53 38 100
DIOVAN 66 66 38 26
LOVASTATIN 65 40 40 24
MIRTAZAPINE 65 53 40 27
SYMBICORT 64 52 42 151
LANTUS 63 58 43 49
LIPITOR 63 56 43 33
LISINOPRIL-HYDROCHLOROTHIAZIDE 62 48 45 31
GLIPIZIDE 62 51 45 45
AMITRIPTYLINE HCL 61 45 R 47 75
GLYBURIDE 60 57 R 48 53
RANITIDINE HCL 57 50 49 30
CRESTOR 56 27 50 29
NEXIUM 54 27 51 56
DEXILANT 54 33 51 182
PAROXETINE HCL 54 32 51 46
NAPROXEN 53 38 54 98
ALPRAZOLAM 52 35 55 78
SPIRIVA 52 36 55 43
GLIPIZIDE XL 52 27 55 123
AZITHROMYCIN 52 32 55 51
ACETAMINOPHEN-CODEINE 50 32 S3 59 142
DIGOXIN 50 39 59 58
CARISOPRODOL 50 0 R 59 180
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 3, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.